• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of analytical package reviews received via FDA's electronic Compliance Management System (CMS) that meet Office of Compliance (OC) timeframes as specified in CMS in the quarter

Dictionary: FDA ensures the safety of regulated products in part by performing laboratory analyses that monitor compliance with its regulations. If foods, dietary supplements or cosmetics are found to contain potentially unsafe contaminants during FDA laboratory analyses then the analytical packages must be reviewed to determine if they support regulatory action. Improving the efficiency of analytical regulatory package reviews will speed enforcement actions and more rapidly ensure the safety of U.S. foods, dietary supplements and cosmetics by removing potentially harmful products from the marketplace.

Information is current as of December 31, 2013.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetPercentage
Oct-Dec 2009N/AN/A
Jan-Mar 2010N/A100
Apr-Jun 2010N/A100
Jul-Sep 2010N/A91

FY 2010 9-Month Overall: 94%

Number of analytical package reviews received via CMS that meet OC timeframes in the quarter

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct-Dec 2009N/AN/A
Jan-Mar 2010N/A5
Apr-Jun 2010N/A32
Jul-Sep 2010N/A58

FY 2010 9-Month Total: 95

Total number of analytical packages reviewed within CMS in the quarter

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct-Dec 2009N/AN/A
Jan-Mar 2010N/A5
Apr-Jun 2010N/A32
Jul-Sep 2010N/A64

FY 2010 9-Month Total: 101

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.